tm logo
K KNACK PHARMACEUTICALS YOUR HEALTH PARTNER
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 18 Jun 2024

Last Applicant/ Owned by

885 Third Avenue, 17th Floor

New York

NY

10022

Serial Number

97425841 filed on 24th May 2022

Registration Number

N/A

Correspondent Address

Tomas M. Casalins

Tomas M. Casalins FOX HORAN & CAMERINI LLP

NEW YORK, NY 10022

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

K KNACK PHARMACEUTICALS YOUR HEALTH PARTNER

Advertising planning; Advertising services, public relations and marketing services, namely, promoting and marketing the goods and services of others through all public communication means; Business management; Business operation, business administration and office functions Pharmaceutical preparations for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations for t Read More

Classification Information


Class [035]
Advertising, Business & Retail Services


Advertising planning; Advertising services, public relations and marketing services, namely, promoting and marketing the goods and services of others through all public communication means; Business management; Business operation, business administration and office functions


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations for the treatment and prevention of neurodegenerative diseases and disorders; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of pain and neuropathic pain; Pharmaceutical preparations for the treatment and prevention of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of respiratory system diseases and disorders; Pharmaceutical preparations for the treatment and prevention of skin diseases, allergies and rheumatic disorders; Pharmaceutical preparations for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Pharmaceutical preparations for the treatment and prevention of Alzheimer's disease; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of ophthalmic related disorders and diseases; Pharmaceutical preparations for the treatment and prevention of musculoskeletal related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of hormone disorders and deficiencies; Pharmaceutical preparations for the treatment and prevention of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the treatment and prevention of metabolic, endocrine and kidney related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of nausea and vomiting; Pharmaceutical preparations for the treatment and prevention of AIDS-related disorders and diseases; Pharmaceutical preparations for the treatment and prevention of viral and bacterial infections; Pharmaceutical preparations for the treatment of exposure to toxic agents; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the support and promotion of bone strength and health; Pharmaceutical preparations for use as injectable anesthetics; Pharmaceutical preparations for use as contraceptives; Pharmaceutical preparations for fertility enhancement purposes; Pharmaceutical preparations for use in hormone replacement therapy; Pharmaceutical preparations for inducing labor and facilitating nursing; Pharmaceutical preparations, namely, injectable contraceptives


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97425841

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
18th Jun 2024SOU EXTENSION 2 FILED
18th Jun 2024SOU EXTENSION 2 GRANTED
18th Jun 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18th Jun 2024SOU TEAS EXTENSION RECEIVED
01st May 2024ASSIGNED TO EXAMINER
21st Dec 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19th Dec 2023SOU EXTENSION 1 GRANTED
19th Dec 2023SOU EXTENSION 1 FILED
19th Dec 2023SOU TEAS EXTENSION RECEIVED
13th Nov 2023ASSIGNED TO EXAMINER